Ellis Investment Partners’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-658
Closed -$84K – 295
2022
Q3
$84K Buy
658
+5
+0.8% +$721 0.02% 314
2022
Q2
$92K Buy
653
+5
+0.8% +$714 0.02% 313
2022
Q1
$90K Buy
648
+5
+0.8% +$766 0.02% 335
2021
Q4
$112K Buy
+643
New +$107K 0.03% 305
2021
Q2
– Sell
-10
Closed -$2K – 779
2021
Q1
$2K Hold
10
– – ﹤0.01% 718
2020
Q4
$2K Hold
10
– – ﹤0.01% 682
2020
Q3
$2K Hold
10
– – ﹤0.01% 672
2020
Q2
$2K Hold
10
– – ﹤0.01% 664
2020
Q1
$1K Hold
10
– – ﹤0.01% 672
2019
Q4
$1K Hold
10
– – ﹤0.01% 659
2019
Q3
$1K Hold
10
– – ﹤0.01% 676
2019
Q2
$1K Buy
+10
New +$1.53K ﹤0.01% 633

Other funds holding CLX

Ellis Investment Partners's CLX Position: Q4 2022 in Review

Ellis Investment Partners sold out of Clorox (CLX) in Q4 2022, closing a stake of 658 shares — an estimated $84K sold.

Ellis Investment Partners first reported a position in CLX in Q2 2019 and held it in 12 quarters. The position peaked at $112K in Q4 2021. 1,105 funds tracked by Wall St. Rank hold CLX as of Q4 2022.

  • Ellis Investment Partners reported no remaining Clorox position as of Q4 2022 after selling out during the quarter.
  • Ellis Investment Partners sold 658 Clorox shares in Q4 2022, an estimated $84K.
  • Ellis Investment Partners first reported a position in Clorox in Q2 2019 and held it in 12 quarters.
  • Ellis Investment Partners's Clorox position peaked at $112K in Q4 2021.
  • 1,105 funds tracked by Wall St. Rank held Clorox as of Q4 2022.

Based on Ellis Investment Partners's 13F filing for Q4 2022, filed 31 Jan 2023.